Kenneth Hess - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Kenneth Hess

Showing results (91-100 of 94) with videos related to

Pageof 10

Sort By:

You have reached the last page of results.This site can display upto 94 results.

British Journal of Cancer|April 27, 2018

Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancersShiraj Sen, Shumei Kato, Rishi Agarwal, et al.

ESMO Open|October 24, 2020

Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignanciesAparna Hegde, Alexander Y Andreev-Drakhlin, Jason Roszik, et al.

Journal for Immunotherapy of Cancer|October 24, 2020

Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom InventoryTito Mendoza, Ajay Sheshadri, Mehmet Altan, et al.

Cell|January 30, 2016

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse GliomaMichele Ceccarelli, Floris P Barthel, Tathiane M Malta, et al.

Pageof 10

Search research articles

Showing results (91-100 of 94) with videos related to

Sort By:

Pageof 10

You have reached the last page of results.This site can display upto 94 results.

British Journal of Cancer|April 27, 2018

Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancersShiraj Sen, Shumei Kato, Rishi Agarwal, et al.

ESMO Open|October 24, 2020

Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignanciesAparna Hegde, Alexander Y Andreev-Drakhlin, Jason Roszik, et al.

Journal for Immunotherapy of Cancer|October 24, 2020

Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom InventoryTito Mendoza, Ajay Sheshadri, Mehmet Altan, et al.

Cell|January 30, 2016

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse GliomaMichele Ceccarelli, Floris P Barthel, Tathiane M Malta, et al.

Pageof 10